Real-Life Experience of Efficacy and Safety of Bilastine in the Refractory Cases of Chronic Spontaneous Urticaria and its Effect on the Quality of Life of Patients

INTRODUCTION: Second-generation H1-antihistamines (SGAHs) are the mainstay of treatment of chronic spontaneous urticaria (CSU). Bilastine, newer non-sedating SGAHs, was recently introduced in India after the approval of the Drugs Controller General of India. There is a paucity of evidence about the...

Descripción completa

Detalles Bibliográficos
Autores principales: De, Abhishek, Godse, Kiran, Dhoot, Dhiraj, Sarda, Aarti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208247/
https://www.ncbi.nlm.nih.gov/pubmed/34188271
http://dx.doi.org/10.4103/ijd.IJD_771_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208247/
https://www.ncbi.nlm.nih.gov/pubmed/34188271
http://dx.doi.org/10.4103/ijd.IJD_771_20

Ejemplares similares